References
- Cines DB, Bussel JB, Liebman HA, et al. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113(26):6511–6521.
- Cines DB, Liebman HA, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009;46(1):S2-S14.
- Dimaggio D, Anderson A, Bussel JB. Cytomegalovirus can make immune thrombocytopenic purpura refractory. Br J Haematol. 2009;146(1):104–112.
- Shimanovsky A, Patel D, Wasser JS. Refractory immune thrombocytopenic purpura and cytomegalovirus infection: A call for a change in the current guidelines. Mediterr J Hematol Infect Dis. 2016;8(1):2016010.
- Young LS, Yap LF, Murray PG. Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer. 2016;16(12):789–802.
- Wu Z, Zhou J, Wei X, et al. The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopenia. Hematology. 2013;18(5):295–299.
- Kanegane H, Miyawaki T, Iwai K, et al. Acute thrombocytopenic purpura associated with primary Epstein-Barr virus infection. Pediatr Int. 1994;36(4):423–426.
- Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386–2393.
- Martinez OM, Krams SM. The immune response to epstein barr virus and implications for posttransplant lymphoproliferative disorder. Transplantation. 2017;101(9):2009–2016.
- Smatti MK, Alsadeq DW, Ali NH, et al. Epstein–Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update. Front Oncol. 2018;8. DOI:10.3389/fonc.2018.00211
- Thorleylawson DA, Gross AJ. Persistence of the Epstein–Barr virus and the origins of associated lymphomas. N Engl J Med. 2004;350(13):1328–1337.
- Schulze H, Gaedicke G. Immune thrombocytopenia in children and adults: what’s the same, what’s different? Haematologica. 2011;96(12):1739–1741.
- Rinaldi M, Perricone C, Ortegahernandez OD, et al. Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines. Lupus. 2014;23(6):554–567.
- Likic R, Kuzmanic D. Severe thrombocytopenia as a complication of acute Epstein-Barr virus infection. Wien Klin Wochenschr. 2004;116(1–2):47–50.
- Hsiao CC. Epstein-Barr virus associated with immune thrombocytopenic purpura in childhood: A retrospective study. J Paediatrics Child Health. 2000;36(5):445–448.
- Walling DM, Brown AL, Etienne W, et al. Multiple Epstein-Barr virus infections in healthy individuals. J Virol. 2003;77(11):6546–6550.
- Kanakry JA, Hegde A, Durand CM, et al. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. 2016;127(16):2007–2017.
- Ryan JL, Fan H, Swinnen LJ, et al. Epstein-Barr Virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies. Diagn Mol Pathol. 2004;13(2):61–68.
- Chan KCA, Zhang J, Chan ATC, et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res. 2003;63(9):2028.
- Swinkels M, Rijkers M, Voorberg J, et al. Emerging concepts in immune thrombocytopenia. Front Immunol. 2018;9(880). DOI:10.3389/fimmu.2018.00880
- Moon UY, Park SJ, Oh ST, et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther. 2004;6(4):1–8.
- Draborg AH, Duus K, Houen G. Epstein-Barr virus in systemic autoimmune diseases. Clin Dev Immunol. 2013;2013:535738.
- Lambert MP, Gernsheimer T. Clinical updates in adult immune thrombocytopenia. Blood. 2017;129(21):2829–2835.
- Stasi R. Immune thrombocytopenia: pathophysiologic and clinical update. Semin Thromb Hemost. 2012;38(5):454–462.